Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. 03759
03759 logo

03759 Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy PHARMARON (03759) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast 03759 stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast 03759 stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 20.920
sliders
Low
0
Averages
0
High
0
0
Current: 20.920
sliders
Low
0
Averages
0
High
0
Nomura
Nomura
Buy
maintain
AI Analysis
2026-04-01
Reason
Nomura
Nomura
Price Target
AI Analysis
2026-04-01
maintain
Buy
Reason
Nomura maintains a Buy rating on PHARMARON due to the company's strong 4Q25 results, which met expectations with a 16% revenue growth and a 41% increase in earnings year-over-year. The management's guidance for 2026 revenue growth of 12-18% aligns with market expectations and exceeds Nomura's previous estimates. As a result, Nomura has raised its target price for the stock.
Nomura
Nomura
Buy
maintain
2026-04-01
Reason
Nomura
Nomura
Price Target
2026-04-01
maintain
Buy
Reason
Nomura maintains a 'Buy' rating on Kanglong Chemical due to strong fourth-quarter results that met expectations, with significant year-on-year revenue and profit growth. The company's guidance for 2026 revenue growth aligns with market expectations and exceeds Nomura's previous estimates. Additionally, the growth in the CMC business and recent investments support a positive outlook, leading to an adjustment in revenue and profit forecasts.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for 03759
Unlock Now

People Also Watch